Page 215 - Read Online

Infante et al. PML after rituximab

multifocal leukoencephalopathy: a review of the neuroimaging leukoencephalopathy following treatment with rituximab in an HIV-
features and differential diagnosis. Eur J Neurol 2012;19:1060-9. negative patient with non-Hodgkin lymphoma. A case report and
2. Yokoyama H, Watanabe T, Maruyama D, Kim SW, Kobayashi Y, literature review. Neuroradiol J 2014;27:657-64.
Tobinai K. Progressive multifocal leukoencephalopathy in a patient 8. Lima MA. Progressive multifocal encephalopathy: new concepts. Arq
with B-cell lymphoma during rituximab-containing chemotherapy: Neuropsiquiatr 2013;71:699-702.
case report and review of the literature. Int J Hematol 2008;88:443-7. 9. Garrote H, de la Fuente A, Oña R, Rodríguez I, Echevarría JE,
3. Tan CS, Koralnik IJ. Beyond progressive multifocal Sepúlveda JM, García JF. Long-term survival in a patient with
leukoencephalopathy: expanded pathogenesis of JC virus infection in progressive multifocal leukoencephalopathy after therapy with
the central nervous system. Lancet Neurol 2010;9:425-37. rituximab, fludarabine and cyclophosphamide for chronic lymphocytic
4. Clavel G, Moulignier A, Semerano L. Progressive multifocal leukemia. Exp Hematol Oncol 2015;4:8.
leukoencephalopathy and rheumatoid arthritis treatments. Joint Bone 10. Chakraborty S, Tarantolo SR, Treves J, Sambol D, Hauke RJ, Batra
Spine 2017; doi: 10.1016/j.jbspin.2017.03.002. SK. Progressive multifocal leukoencephalopathy in a HIV-negative
5. Molloy ES, Calabrese CM, Calabrese LH. The risk of progressive patient with small lymphocytic leukemia following treatment with
multifocal leukoencephalopathy in the biologic era: prevention and rituximab. Case Rep Oncol 2011;4:136-42.
management. Rheum Dis Clin North Am 2017;43:95-109. 11. Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP,
6. Ohta K, Obara K, Sakauchi M, Obara K, Takane H, Yogo Y. Lesion Bennett CL. Monoclonal antibody-associated progressive multifocal
extension detected by diffusion-weighted magnetic resonance leucoencephalopathy in patients treated with rituximab, natalizumab,
imaging in progressive multifocal leukoencephalopathy. J Neurol and efalizumab: a review from the Research on Adverse Drug Events
2001;248:809-11. and Reports (RADAR) Project. Lancet Oncol 2009;10:816-24.
7. Felli V, Di Sibio A, Anselmi M, Gennarelli A, Sucapane P, Splendiani 12. Stasi R. Rituximab in autoimmune hematologic diseases: not just a
A, Catalucci A, Marini C, Gallucci M. Progressive multifocal matter of B cells. Semin Hematol 2010;47:170-9.

Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ October 19, 2017 215